Mossop

Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer

*Radiotherapy and Oncology* 2020; 142:62-71

The association between vitamin D status and clinical events in high-risk older patients with non-ST elevation acute coronary syndrome undergoing invasive management

*PLoS ONE* 2019; 14(6):e0217476

Brief alcohol intervention for risky drinking in young people aged 14–15 years in secondary schools: The SIPS JR-HIGH RCT

*Public Health Research* 2019; 7(9)

Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis

*Thorax* 2019; 74(4):346-353

Cognitive decline in older patients with non-ST elevation acute coronary syndrome

*Journal of the American Heart Association* 2019; 8(4):e011218

ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): Study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial

*Trials* 2018; 19:616